86 related articles for article (PubMed ID: 23714256)
1. Prognostic utility of quantitative image analysis of microvascular density in prostate cancer.
Ozerdem U; Wojcik EM; Duan X; Erşahin Ç; Barkan GA
Pathol Int; 2013 May; 63(5):277-82. PubMed ID: 23714256
[TBL] [Abstract][Full Text] [Related]
2. A practical application of quantitative vascular image analysis in breast pathology.
Ozerdem U; Wojcik EM; Barkan GA; Duan X; Erşahin Ç
Pathol Res Pract; 2013 Jul; 209(7):455-8. PubMed ID: 23707548
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.
Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A
Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258
[TBL] [Abstract][Full Text] [Related]
4. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
Ozerdem U
Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
[TBL] [Abstract][Full Text] [Related]
5. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.
Miyata Y; Ohba K; Matsuo T; Watanabe S; Hayashi T; Sakai H; Kanetake H
Urology; 2013 Jan; 81(1):136-42. PubMed ID: 23149328
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis.
Goes RS; Carvalho JP; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho FM
Int J Gynecol Pathol; 2012 Jan; 31(1):8-14. PubMed ID: 22123718
[TBL] [Abstract][Full Text] [Related]
10. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens.
Kryvenko ON; Epstein JI
Am J Surg Pathol; 2012 Dec; 36(12):1865-73. PubMed ID: 23154772
[TBL] [Abstract][Full Text] [Related]
11. Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores.
Kuroda K; Horiguchi A; Asano T; Asano T; Hayakawa M
Prostate; 2008 Jul; 68(10):1057-63. PubMed ID: 18386298
[TBL] [Abstract][Full Text] [Related]
12. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Welén K; Jennbacken K; Tesan T; Damber JE
Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
Li R; Younes M; Wheeler TM; Scardino P; Ohori M; Frolov A; Ayala G
Prostate; 2004 Feb; 58(2):193-9. PubMed ID: 14716745
[TBL] [Abstract][Full Text] [Related]
14. Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchyma.
Taverna G; Colombo P; Grizzi F; Franceschini B; Ceva-Grimaldi G; Seveso M; Giusti G; Piccinelli A; Graziotti P
Pathol Res Pract; 2009; 205(7):438-44. PubMed ID: 19232838
[TBL] [Abstract][Full Text] [Related]
15. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density and lymph node metastasis in prostate cancer.
Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
[TBL] [Abstract][Full Text] [Related]
17. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
Trojan L; Thomas D; Friedrich D; Grobholz R; Knoll T; Alken P; Michel MS
Anticancer Res; 2004; 24(3a):1651-6. PubMed ID: 15274336
[TBL] [Abstract][Full Text] [Related]
18. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
[TBL] [Abstract][Full Text] [Related]
20. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer.
Donovan MJ; Khan FM; Bayer-Zubek V; Powell D; Costa J; Cordon-Cardo C
BJU Int; 2012 Jan; 109(2):207-13. PubMed ID: 21733075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
